Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-12-14

FDA Approved: ALTAFLUOR — Original Application (Altaire Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved AltaFluor, an ophthalmic solution combining fluorescein sodium with benoxinate hydrochloride, under an original application.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALTAFLUOR (Fluorescein sodium and benoxinate hydrochloride)

Snippet

ORIG AP for ALTAFLUOR (FLUORESCEIN SODIUM AND BENOXINATE HYDROCHLORIDE)